Evidence map›Paper›PMID 24172696›Full record

ArticleThe review of diabetic studies : RDS2013

Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study.

Christina Chrysohoou, Demosthenes Panagiotakos, Christos Pitsavos, Gerasimos Siasos, Evangelos Oikonomou, John Varlas, Athanasios Patialiakas, George Lazaros, Theodora Psaltopoulou, Marina Zaromitidou and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The review of diabetic studies : RDS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Anti-Inflammatory Effects of Testosterone.Journal of the Endocrine Society · 2019
    Review
  9. Review
  10. Review
  11. Testosterone, aging and survival: biomarker or deficiency.Current opinion in endocrinology, diabetes, and obesity · 2014
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Christina ChrysohoouFirst Cardiology Clinic, Hippokration Hospital, Medical School, University of Athens, Athens, Greece.
Demosthenes Panagiotakos
Christos Pitsavos
Gerasimos Siasos
Evangelos Oikonomou
John Varlas
Athanasios Patialiakas
George Lazaros
Theodora Psaltopoulou
Marina Zaromitidou
Polina Kourkouti
Dimitris Tousoulis
Christodoulos Stefanadis
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of the metabolic syndrome (MetS) increases with age. Among other changes, testosterone levels decline with age. The relationship between testosterone levels and MetS components in older subjects has not been clearly defined until today.

objectivesThe aim of this work was to evaluate the relationship between total serum testosterone levels and MetS and its components.

methodsThe working sample consisted of 467 elderly individuals (mean age 75 ± 6 years old, n = 220 men) from Ikaria Island, Greece. MetS was defined according to the NCEP ATPIII criteria.

resultsMetS prevalence was 52% in men and 64% in women. Those with MetS had lower testosterone levels; a 10 ng/dl increase in testosterone was associated with a 3% reduction in odds of having MetS in men (95% CI: 0.95-0.99), but not in women. This remained the result after various adjustments had been made, including daily hours of sleep. Testosterone was inversely associated with abnormal waist circumference, high-sensitivity C-reactive protein (hs-CRP), insulin, and HDL cholesterol levels in men only. When lipid categories, hs-CRP, BMI, and insulin resistance levels were taken into account, testosterone lost its significance in predicting MetS (p < 0.20), suggesting that these markers possess a mediating effect.

conclusionsIn elderly men, low serum testosterone was associated with MetS. Lipids, BMI, inflammation, and insulin resistance levels seem to explain this relationship, suggesting a potential mediating effect. This finding may support a research hypothesis relating serum testosterone to cardiovascular disease, which requires further research.

Indexed as

Insulin ResistanceAgedAged, 80 and overBody WeightCholesterol, HDLC-Reactive ProteinFemaleGreeceHumansInflammationInsulinLipidsMaleMetabolic SyndromeTestosteroneTriglyceridesCholesterol, HDLC-Reactive ProteinInsulinLipidsTestosteroneTriglycerides

Identifiers

PMID24172696
PMCPMC3932069
OpenAlexW290180496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.